BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8164424)

  • 1. The biophysical basis of hypofiltration in nephrotic humans with membranous nephropathy.
    Ting RH; Kristal B; Myers BD
    Kidney Int; 1994 Feb; 45(2):390-7. PubMed ID: 8164424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of glomerular hypofiltration in nephrotic patients with minimal change nephropathy.
    Guasch A; Myers BD
    J Am Soc Nephrol; 1994 Feb; 4(8):1571-81. PubMed ID: 8025231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of progressive glomerular injury in membranous nephropathy.
    Squarer A; Lemley KV; Ambalavanan S; Kristal B; Deen WM; Sibley R; Anderson L; Myers BD
    J Am Soc Nephrol; 1998 Aug; 9(8):1389-98. PubMed ID: 9697660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent and course of glomerular injury in human membranous glomerulopathy.
    Guasch A; Sibley RK; Huie P; Myers BD
    Am J Physiol; 1992 Dec; 263(6 Pt 2):F1034-43. PubMed ID: 1282782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
    Ruggenenti P; Mosconi L; Vendramin G; Moriggi M; Remuzzi A; Sangalli F; Remuzzi G
    Am J Kidney Dis; 2000 Mar; 35(3):381-91. PubMed ID: 10692263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerular function in advanced human diabetic nephropathy.
    Winetz JA; Golbetz HV; Spencer RJ; Lee JA; Myers BD
    Kidney Int; 1982 May; 21(5):750-6. PubMed ID: 6180214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for reduced glomerular filtration capacity in nephrotic humans.
    Drumond MC; Kristal B; Myers BD; Deen WM
    J Clin Invest; 1994 Sep; 94(3):1187-95. PubMed ID: 8083359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome.
    Zietse R; Wenting GJ; Kramer P; Schalekamp MA; Weimar W
    Clin Sci (Lond); 1992 Jun; 82(6):641-50. PubMed ID: 1320544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of GFR depression in early membranous nephropathy.
    Hladunewich MA; Lemley KV; Blouch KL; Myers BD
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1014-22. PubMed ID: 12527555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membranous nephropathy presenting with nephrotic syndrome in a child with thalassemia major.
    Yavuz S; Anarat A; Bayazıt AK; Karagun BŞ; Yılmaz S; Kılınc Y; Gonlusen G; Kuyucu Y
    Pediatr Int; 2015 Aug; 57(4):711-3. PubMed ID: 25711242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrotic syndrome associated with fibrillary deposits in the glomeruli.
    Yumura W; Nitta K; Horita S; Ozu H; Honda K; Nihei H
    Intern Med; 1995 Jan; 34(1):46-50. PubMed ID: 7718980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular configuration and glomerular size selectivity in healthy and nephrotic humans.
    Blouch K; Deen WM; Fauvel JP; Bialek J; Derby G; Myers BD
    Am J Physiol; 1997 Sep; 273(3 Pt 2):F430-7. PubMed ID: 9321916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of glomerular hypofiltration in aging humans.
    Hoang K; Tan JC; Derby G; Blouch KL; Masek M; Ma I; Lemley KV; Myers BD
    Kidney Int; 2003 Oct; 64(4):1417-24. PubMed ID: 12969161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistence of Anti-Glomerular Basement Membrane Glomerulonephritis and Membranous Nephropathy in a Female Patient with Preserved Renal Function.
    Ogawara A; Harada M; Ichikawa T; Fujii K; Ehara T; Kobayashi M
    Tohoku J Exp Med; 2017 Dec; 243(4):335-341. PubMed ID: 29269610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enalapril can treat the proteinuria of membranous glomerulonephritis without detriment to systemic or renal hemodynamics.
    Thomas DM; Hillis AN; Coles GA; Davies M; Williams JD
    Am J Kidney Dis; 1991 Jul; 18(1):38-43. PubMed ID: 1712151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar® Gel) in nephrotic syndrome due to idiopathic membranous nephropathy.
    Hladunewich MA; Cattran D; Beck LH; Odutayo A; Sethi S; Ayalon R; Leung N; Reich H; Fervenza FC
    Nephrol Dial Transplant; 2014 Aug; 29(8):1570-7. PubMed ID: 24714414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular capillary wall function in human lupus nephritis.
    Friedman S; Strober S; Field EH; Silverman E; Myers BD
    Am J Physiol; 1984 May; 246(5 Pt 2):F580-91. PubMed ID: 6720964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between histologic features and glomerular permeability in membranous nephropathy and immunoglobulin A nephropathy.
    Ikegaya N; Nagase M; Honda N; Kumagai H; Hishida A
    J Lab Clin Med; 1994 Jan; 123(1):94-101. PubMed ID: 7507157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome.
    Kosmadakis G; Filiopoulos V; Georgoulias C; Tentolouris N; Michail S
    Scand J Urol Nephrol; 2010 Sep; 44(4):251-6. PubMed ID: 20201749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of glomerulotubular balance in the setting of heterogeneous glomerular injury. Preservation of a close functional linkage between individual nephrons and surrounding microvasculature.
    Ichikawa I; Hoyer JR; Seiler MW; Brenner BM
    J Clin Invest; 1982 Jan; 69(1):185-98. PubMed ID: 7054238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.